Compare LSTR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSTR | GRFS |
|---|---|---|
| Founded | 1988 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.8B |
| IPO Year | 1994 | N/A |
| Metric | LSTR | GRFS |
|---|---|---|
| Price | $166.93 | $8.02 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $153.67 | $10.15 |
| AVG Volume (30 Days) | 348.7K | ★ 752.7K |
| Earning Date | 04-28-2026 | 07-28-2022 |
| Dividend Yield | ★ 2.18% | 1.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.31 | N/A |
| Revenue | ★ $4,743,760,000.00 | N/A |
| Revenue This Year | $6.67 | $5.33 |
| Revenue Next Year | $9.06 | $6.50 |
| P/E Ratio | $49.94 | ★ $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $119.40 | $6.19 |
| 52 Week High | $166.11 | $11.14 |
| Indicator | LSTR | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 68.86 | 47.16 |
| Support Level | $142.52 | $7.52 |
| Resistance Level | N/A | $9.11 |
| Average True Range (ATR) | 4.96 | 0.22 |
| MACD | 1.55 | 0.10 |
| Stochastic Oscillator | 87.35 | 71.28 |
Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.